Author: Wellgistics Health, Inc.

Posted Date:

April 14, 2026

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Wellgistics Health, Inc.

April 14, 2026
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Health, Inc.

March 23, 2026
Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

Wellgistics Health, Inc.

March 19, 2026
Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction

Wellgistics Health, Inc.

March 13, 2026
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities

Wellgistics Health, Inc.

March 11, 2026
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)

Wellgistics Health, Inc.

March 9, 2026
Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate

Wellgistics Health, Inc.

March 5, 2026
DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts

Wellgistics Health, Inc.

February 23, 2026
Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup

Wellgistics Health, Inc.

February 18, 2026
Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion

Wellgistics Health, Inc.

February 11, 2026